University of Michigan Medicine is a clinical research site located in Ann Arbor, Michigan, United States 48109.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Michigan Medicine has participated in 8 clinical trials with 6 currently active.
Therapeutic areas: Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer, Hormone Receptor Positive Breast Adenocarcinoma.
Sponsors: Radionetics Oncology, Novo Nordisk A/S, Oregon Health and Science University.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Michigan Medicine has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Michigan Medicine has 8 clinical trials on record, with 6 currently active. Their work covers Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer, Hormone Receptor Positive Breast Adenocarcinoma.
Yes — University of Michigan Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.